Background: In cardiac surgery, the N-terminal pro-brain natriuretic peptide (NT-proBNP) level is reportedly correlated with the onset of postoperative complications. We examined the relationship between the NT-proBNP level and perioperative complications in thoracic surgery and elucidated the significance of NT-proBNP measurement. Methods: We evaluated 48 patients excluding hemodialysis patients who underwent lung resection from November 2015 to February 2016. NT-proBNP measurement was performed three times preoperatively on postoperative days 2 and 5. We examined the relationship between clinical background factors such as preoperative comorbidity and the development of postoperative complications. Based on established criteria for surgical complications (Clavien-Dindo classification), grade ≥ II was defined as a complications. We classified the patients into two groups (with or without complications) and compared and examined the background factors between the groups. Results: The study included 48 patients (33 male, 15 female) with an average age of 72 years (range, 35 - 86 years). Preoperative comorbidities included cardiovascular disease in five patients, diabetes mellitus in four, and chronic obstructive pulmonary disease in six. The average operation time was 163 (29 - 308) minutes, and the bleeding volume was 30 (10 - 620) ml. Early complications were confirmed in 11 patients, and late complications were confirmed in 7 patients. A high NT-proBNP level on postoperative day 5 was an independent risk factor for late complications. Conclusion: The perioperative NT-proBNP level is considered to be a predictor of complications. Its measurement is useful for predicting postoperative complications, and careful perioperative management is required for patients with high levels.
References
[1]
Hunt, P.J., Richards, A.M., Nicholls, M.G., Yandle, T.G., Doughty, R.N. and Espiner, E.A. (1997) Immunoreactive Amino-Terminal Pro-Brain Natriuretic Peptide (NT-PROBNP): A New Marker of Cardiac Impairment. Clinical Endocrinology, 47, 287-296. https://doi.org/10.1046/j.1365-2265.1997.2361058.x
[2]
Nojiri, T., Inoue, M., Takeuchi, Y., Maeda, H., Shintani, Y., Sawabata, N., et al. (2015) Impact of Cardiopulmonary Complications of Lung Cancer Surgery on Long-Term Outcomes. Surgery Today, 45, 740-745.
https://doi.org/10.1007/s00595-014-1032-z
[3]
Colinet, B., Jacot, W., Bertrand, D., Lacombe, S., Bozonnat, M.C., Daurès, J.P., et al. (2005) A New Simplified Comorbidity Score as a Prognostic Factor in Non-Small-Cell Lung Cancer Patients: Description and Comparison with the Charlson’s Index. British Journal of Cancer, 93, 1098-1105.
https://doi.org/10.1038/sj.bjc.6602836
[4]
Dindo, D., Demartines, N. and Clavien, P.A. (2004) Classification of Surgical Complications: A New Proposal with Evaluation in a Cohort of 6336 Patients and Results of a Survey. Annals of Surgery, 240, 205-213.
https://doi.org/10.1097/01.sla.0000133083.54934.ae
[5]
Clavien, P.A., Barkun, J., de Oliveira, M.L., Vauthey, J.N., Dindo, D., Schulick, R.D., et al. (2009) The Clavien-Dindo Classification of Surgical Complications: Five-Year Experience. Annals of Surgery, 250, 187-196.
https://doi.org/10.1097/SLA.0b013e3181b13ca2
[6]
Nojiri, T., Maeda, H., Takeuchi, Y., Funakoshi, Y., Kimura, T., Maekura, R., et al. (2010) Predictive Value of B-Type Natriuretic Peptide for Postoperative Atrial Fibrillation Following Pulmonary Resection for Lung Cancer. European Journal of Cardio-Thoracic Surgery, 37, 787-791. https://doi.org/10.1016/j.ejcts.2009.09.043
[7]
Nojiri, T., Inoue, M., Yamamoto, K., Maeda, H., Takeuchi, Y., Funakoshi Y., et al. (2011) B-Type Natriuretic Peptide as a Predictor of Postoperative Cardiopulmonary Complications in Elderly Patients Undergoing Pulmonary Resection for Lung Cancer. The Annals of Thoracic Surgery, 92, 1051-1055.
https://doi.org/10.1016/j.athoracsur.2011.03.085
[8]
Daniels, L.B. and Maisel, A.S. (2007) Natriuretic Peptides. Journal of the American College of Cardiology, 50, 2357-2368. https://doi.org/10.1016/j.jacc.2007.09.021
[9]
Hou, J.L., Gao, K., Li, M., Ma, J.Y., Shi, Y.K., Wang, Y., et al. (2008) Increased N-Terminal Pro-Brain Natriuretic Peptide Level Predicts Atrial Fibrillation after Surgery for Esophageal Carcinoma. World Journal of Gastroenterology, 14, 2582-2585.
[10]
Nagaya, N., Nishikimi, T., Okano, Y., Uematsu, M., Satoh, T., Kyotani, S., et al. (1998) Plasma Brain Natriuretic Peptide Levels Increase in Proportion to the Extent of Right Ventricular Dysfunction in Pulmonary Hypertension. Journal of the American College of Cardiology, 31, 202-208.
https://doi.org/10.1016/S0735-1097(97)00452-X
[11]
Inoue, Y., Kawayama, T., Iwanaga, T. and Aizawa, H. (2009) High Plasma Brain Natriuretic Peptide Levels in Stable COPD without Pulmonary Hypertension or Cor Pulmonale. Internal Medicine Journal, 48, 503-512.